AVIGEN LTD
Company number 16211696 · Active · London W12 7RZ
AVIGEN LTD is an active private limited company (company number 16211696) incorporated on 27 January 2025, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 January 2026, showing net assets of £262k, with 3 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Key dates
- Incorporated
- 27 January 2025
- Next accounts due
- 31 October 2027 — in 378 days
- Confirmation statement due
- 10 February 2027 — in 115 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- Micro (Companies Act thresholds)
Financials — 1 period on record, latest ending 31 January 2026
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 January 2026 | £262k | — | — | — | — | — | 3 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Firmoscan score: 60/100 (grade C)
- +10 Positive net assets — Net assets £262,466 at 2026-01-31
- 0 Newly incorporated — Incorporated 2025-01-27; no accounts due yet
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Mr Tobias Gamper — owns 25–50% of shares; holds 25–50% of voting rights · since 27 January 2025
- Neelima Kc — owns 25–50% of shares; holds 25–50% of voting rights · since 27 January 2025
- Samuel Henry Au — owns 25–50% of shares; holds 25–50% of voting rights · since 27 January 2025 · ceased 7 February 2025
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in London
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- YOUR GENO LTD — London, inc. Jan 2025
- DIGITAL TECHNOLOGY INNOVATIONS LTD — London, inc. Jan 2025
- VERDIVA BIO DEV LIMITED — London, inc. Jan 2025
- BIOGENOUS BIOTECH UK LTD — London, inc. Jan 2025
- INSULSIM LTD — London, inc. Feb 2025
- BIND RESEARCH — London, inc. Jan 2025
Reminders for AVIGEN LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.